NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OncoRes Medical

OncoRes Medical

Private
NedlandsHealthcare & Life Scienceshttps://www.oncoresmedical.com/

Last Round

VC Round

Feb 12, 2026

Total Funding Raised

$20.77M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OncoRes Medical is a medical device company developing a handheld, real-time, intraoperative imaging device to improve the detection of residual tumors during breast-conserving surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

intraoperative imagingbreast cancer surgeryoptical coherence tomographyOCTquantitative micro-elastographyQMEsurgical imagingtumor margin assessmentsurgical guidancemedtechrazor and bladecomputer visionclinical decision supportsurgical oncologymedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoRes Medical Comparables

Compare OncoRes Medical with similar companies based on industry and business-model similarity.

OncoRes Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

OncoRes Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 12, 2026
GrantJul 18, 2023
GrantMay 18, 2022
Series A ExtensionMay 18, 2022
GrantJan 22, 2021
Grant
Dec 18, 2020

Key People

Founding team and executive leadership

Katharine Giles

Managing Director CEO

Executive Team

Simon Graindorge

Chief Operating Officer

Executive Team

OncoRes Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 1252% MoM, reaching 4.7K.

  • May 18, 2022

    $7M round led by Brandon Capital and Australian Unity.

OncoRes Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoRes Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoRes Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNedlands
Employee Range44
Year Founded2016
Last FundingFeb 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.